Literature DB >> 32086850

Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.

Li Fan1, Hai Li1, Weihua Wang1.   

Abstract

NEW
FINDINGS: What is the central question of this study? What is the role of lncRNA PRRT3-AS1 in the regulation of peroxisome proliferator-activated receptor γ (PPARγ) gene-mediated mechanistic target of rapamycin (mTOR) signalling pathway in proliferation, apoptosis and autophagy of prostate cancer cells? What is the main finding and its importance? The targeting relation between lncRNA PRRT3-AS1 and PPARγ was verified, and it was demonstrated that silencing of lncRNA PRRT3-AS1 can upregulate apoptosis and autophagy yet downregulate proliferation, migration and invasion of prostate cancer cells through the mTOR signalling pathway. Further work is needed to consolidate the therapeutic value of lncRNA PRRT3-AS1 in clinical trials and treatment of prostate cancer. ABSTRACT: Although long non-coding RNAs (lncRNAs) are correlated with multiple cancers, their molecular mechanisms in prostate cancer (PC) remain inadequately understood. This study investigated the effects of lncRNA PRRT3-AS1 on the progression of prostate cancer (PC) with involvement of peroxisome proliferator-activated receptor γ (PPARγ). Microarray analysis was used to identify the differentially expressed genes and lncRNAs associated with PC. RT-qPCR and western blot analysis were employed to test the expression of lncRNA PRRT3-AS1, mammalian target of rapamycin (mTOR) signalling pathway-, apoptosis- and autophagy-related genes. A scratch test, Transwell assay, CCK-8 assay, colony formation assay, flow cytometry and monodansylcadaverine staining were employed to identify the migration, invasion, proliferation activity, cell cycle and apoptosis and autophagy of PC3 cells, respectively. Tumorigenicity assays in nude mice were used to detect the tumorigenic ability. GSE55945 and GSE46602 datasets indicated that lncRNA PRRT3-AS1 was highly expressed in PC. PPARγ was predicted as a target gene of lncRNA PRRT3-AS1. Ectopic overexpression of PPARγ or lncRNA PRRT3-AS1 silencing led to inhibited cell viability, migration and invasion, and accelerated apoptosis. Furthermore, the delivery of si-PRRT3-AS1 or PPARγ vector to PC3 cells resulted in the regression of xenografts in nude mice. Based on the in vitro and in vivo experiments, silencing of lncRNA PRRT3-AS1 was observed to activate the PPARγ gene, which in turn could inhibit PC cell proliferation and promote apoptosis and autophagy by blocking the mTOR signalling pathway.
© 2020 The Authors. Experimental Physiology © 2020 The Physiological Society.

Entities:  

Keywords:  PPARγ; apoptosis; autophagy; lncRNA PRRT3-AS1; mTOR signalling pathway; proliferation

Year:  2020        PMID: 32086850     DOI: 10.1113/EP088011

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  14 in total

1.  Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.

Authors:  Xiaolong Tang; Yandong Miao; Jiangtao Wang; Teng Cai; Lixia Yang; Denghai Mi
Journal:  Comput Math Methods Med       Date:  2021-11-11       Impact factor: 2.238

2.  Bioinformatics Analysis for Constructing a Six-Immune-Related Long Noncoding RNA Signature as a Prognostic Model of Hepatocellular Carcinoma.

Authors:  Jue Wang; Zongrui Jin; Guolin Wu; Jilong Wang; Banghao Xu; Hai Zhu; Ya Guo; Zhang Wen
Journal:  Biomed Res Int       Date:  2022-07-07       Impact factor: 3.246

3.  Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.

Authors:  Guo Chen; Xiaoping Qin; Yu Wang; Biyun Gao; Muan Ling; Wenjun Yin; Yutong Li; Bin Pan
Journal:  Cell Cycle       Date:  2022-04-24       Impact factor: 5.173

4.  Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma.

Authors:  Weihao Kong; Xingyu Wang; Xiaomin Zuo; Zhongxiang Mao; Ya Cheng; Wei Chen
Journal:  Front Genet       Date:  2020-09-04       Impact factor: 4.599

5.  Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer.

Authors:  Jiaming Wan; Cheng Guo; Hongpeng Fang; Zhongye Xu; Yongwei Hu; Yun Luo
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

6.  The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma.

Authors:  Shiming Yang; Yaping Zhou; Xiangxin Zhang; Lu Wang; Jianfeng Fu; Xiaotong Zhao; Liu Yang
Journal:  BMC Bioinformatics       Date:  2021-04-28       Impact factor: 3.169

7.  Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.

Authors:  Peng Zhang; Xiaodong Tan; Daoqiang Zhang; Qi Gong; Xuefeng Zhang
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

8.  A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma.

Authors:  Ye Nie; Jianhui Li; Wenlong Wu; Dongnan Guo; Xinjun Lei; Tianchen Zhang; Yanfang Wang; Zhenzhen Mao; Xuan Zhang; Wenjie Song
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

Review 9.  Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.

Authors:  Milad Ashrafizadeh; Mahshid Deldar Abad Paskeh; Sepideh Mirzaei; Mohammad Hossein Gholami; Ali Zarrabi; Farid Hashemi; Kiavash Hushmandi; Mehrdad Hashemi; Noushin Nabavi; Francesco Crea; Jun Ren; Daniel J Klionsky; Alan Prem Kumar; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-03-22

10.  Immune-Related lncRNA Risk Signatures Predict Survival of IDH Wild-Type and MGMT Promoter Unmethylated Glioblastoma.

Authors:  Xiaozhi Li; Yutong Meng
Journal:  Biomed Res Int       Date:  2020-08-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.